This week, Pioneer hosted its annual Hewitt Health Care Lecture, again bringing together influential leaders in medicine, business, and public policy to hear nationally recognized experts discuss our most pressing health care policy challenges. This year, Harvard economist David Cutler and Manhattan Institute Senior Fellow Avik Roy discussed issues relevant to both the ACA (ObamaCare) and the new Massachusetts law (Chapter 224) that attempts to control costs and implement payment reform. The speakers delivered presentations on the problem of rising healthcare costs, followed by a moderated discussion, and audience Q&A.
Check out our Facebook photo album; watch the video:
David Cutler is Otto Eckstein Professor of Applied Economics in the Department of Economics at Harvard and holds secondary appointments at the Kennedy School of Government and the School of Public Health. Cutler served on the Council of Economic Advisers and the National Economic Council during the Clinton Administration and has advised the Presidential campaigns of Bill Bradley, and John Kerry, as well as being Senior Health Care Advisor for the Obama Presidential Campaign. He is a Senior Fellow for the Center for American Progress in Washington, D.C. Among other affiliations, Professor Cutler has held positions with the National Institutes of Health and the National Academy of Sciences. Currently, Professor Cutler is a Research Associate at the National Bureau of Economic Research, and a member of the Institute of Medicine. Cutler was recently named one of the 30 people who could have a powerful impact on healthcare by Modern Healthcare magazine and one of the 50 most influential men aged 45 and younger by Details magazine. Cutler is author of Your Money Or Your Life: Strong Medicine for America’s Health Care System, Professor Cutler received an AB from Harvard University and a PhD in Economics from MIT.
Avik Roy is a senior fellow at the Manhattan Institute. His research interests include Medicare, Medicaid, the Affordable Care Act, and consumer-driven health care. He is author of The Apothecary, the influential Forbes blog on health care policy and entitlement reform. He writes regularly for Forbes and National Review, and his work has also appeared in National Affairs, USA Today, The Atlantic, The American Spectator, and other publications. Roy is also the founder of Roy Healthcare Research, an investment research firm in New York. Previously, he served as an analyst and portfolio manager at J.P. Morgan, Bain Capital, and other firms. He attended the Massachusetts Institute of Technology, where he studied molecular biology, and the Yale University School of Medicine.